NCT00831779 Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00736879 Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00680745 Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT00673231 Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin Status COMPLETED Phase PHASE3
NCT00663260 Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Status COMPLETED Phase PHASE2/PHASE3
NCT00660907 Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT00643851 An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets Status COMPLETED Phase PHASE3
NCT00562250 Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00528879 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Status COMPLETED Phase PHASE3
NCT00528372 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT00357370 A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2/PHASE3
NCT00263276 A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2